Matthew Nguyen
Keine laufenden Positionen mehr
Profil
Matthew Nguyen worked as a Director of New Business Development at Janssen Pharmaceuticals and Janssen LP from 2005 to 2006.
He then worked as the Chief Commercial Officer at Valeritas Holdings, Inc. from 2016 to 2020.
Nguyen earned an MBA from Rutgers State University of New Jersey in 2004.
Prior to that, he earned an undergraduate degree and a doctorate from Philadelphia College of Pharmacy in 1994 and 1996, respectively.
Ehemalige bekannte Positionen von Matthew Nguyen
| Unternehmen | Position | Ende |
|---|---|---|
| VALERITAS HOLDINGS, INC. | Corporate Officer/Principal | 02.04.2020 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01.01.2006 |
Janssen LP
 Janssen LP Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen LP is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Titusville, NJ. | Corporate Officer/Principal | 01.01.2006 |
Ausbildung von Matthew Nguyen
| Rutgers State University of New Jersey | Masters Business Admin |
| Philadelphia College of Pharmacy | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
Janssen LP
Janssen LP Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen LP is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Titusville, NJ. | Health Technology |
